The Procter & Gamble Company (NYSE:PG) Stake Reduced by Physician Wealth Advisors Inc.

Physician Wealth Advisors Inc. reduced its stake in shares of The Procter & Gamble Company (NYSE:PG) by 5.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,270 shares of the company’s stock after selling 265 shares during the quarter. Physician Wealth Advisors Inc.’s holdings in Procter & Gamble were worth $666,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Teza Capital Management LLC grew its stake in shares of Procter & Gamble by 212.9% in the third quarter. Teza Capital Management LLC now owns 4,284 shares of the company’s stock worth $625,000 after purchasing an additional 2,915 shares in the last quarter. Hodges Capital Management Inc. bought a new position in shares of Procter & Gamble in the third quarter worth $1,001,000. Advanced Portfolio Management LLC bought a new position in shares of Procter & Gamble in the third quarter worth $408,000. Axxcess Wealth Management LLC grew its stake in shares of Procter & Gamble by 116.6% in the third quarter. Axxcess Wealth Management LLC now owns 103,378 shares of the company’s stock worth $15,079,000 after purchasing an additional 55,647 shares in the last quarter. Finally, Ellerson Group Inc. ADV bought a new position in shares of Procter & Gamble in the third quarter worth $120,000. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Down 1.0 %

Procter & Gamble stock traded down $1.70 during mid-day trading on Friday, hitting $164.92. The company’s stock had a trading volume of 9,253,317 shares, compared to its average volume of 6,088,934. The firm’s 50 day moving average is $165.60 and its 200 day moving average is $158.81. The company has a market cap of $389.23 billion, a PE ratio of 26.95, a price-to-earnings-growth ratio of 3.35 and a beta of 0.42. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $169.41.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.10. The firm had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The business’s revenue for the quarter was up .6% on a year-over-year basis. During the same period in the prior year, the business earned $1.37 EPS. On average, analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current year.

Procter & Gamble Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th were issued a $1.0065 dividend. The ex-dividend date of this dividend was Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.44%. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio (DPR) is 65.85%.

Analysts Set New Price Targets

PG has been the subject of several research reports. Argus raised their target price on Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Thursday, April 25th. StockNews.com raised Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Tuesday, June 25th. Jefferies Financial Group raised their target price on Procter & Gamble from $175.00 to $182.00 and gave the company a “buy” rating in a research note on Monday, April 22nd. Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and raised their target price for the company from $160.00 to $175.00 in a research note on Monday, March 11th. Finally, Barclays raised their target price on Procter & Gamble from $168.00 to $170.00 and gave the company an “overweight” rating in a research note on Tuesday, April 23rd. Six research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and an average price target of $170.72.

Insider Buying and Selling at Procter & Gamble

In other news, CEO Sundar G. Raman sold 31,924 shares of the business’s stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the sale, the chief executive officer now directly owns 19,042 shares in the company, valued at $3,179,061.90. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, CEO Sundar G. Raman sold 31,924 shares of the business’s stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the sale, the chief executive officer now directly owns 19,042 shares in the company, valued at $3,179,061.90. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Moses Victor Javier Aguilar sold 9,149 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $167.72, for a total value of $1,534,470.28. Following the sale, the insider now owns 12,929 shares in the company, valued at $2,168,451.88. The disclosure for this sale can be found here. Insiders have sold 154,544 shares of company stock valued at $25,413,051 in the last 90 days. 0.17% of the stock is currently owned by insiders.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.